[1]
“Role of Hydroxyurea in Reducing Transfusion Requirements in Patients with β-Thalassaemia Major ”, The Insight, vol. 2, no. 02, p. 7, Sep. 2021, Accessed: Jun. 30, 2025. [Online]. Available: https://www.bdjournals.org/index.php/insight/article/view/78